Department of Emergency, Children's Hospital of Chongqing Medical University, Chongqing, China.
National Clinical Research Center for Child Health and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.
Pediatr Pulmonol. 2022 Sep;57(9):2003-2011. doi: 10.1002/ppul.25943. Epub 2022 Jun 15.
To describe the incidence, clinical features, outcomes, and mortality risk factors of sepsis associated with acute respiratory distress syndrome (ARDS) in pediatric patients.
Patients were included in the study if they met the 2005 version of the International Pediatric Sepsis Consensus Conference and met the Pediatric Acute Lung Injury Consensus Conference (PALICC) definition within 48 h of sepsis diagnosis. Patients were classified as mild, moderate, and severe by the worst oxygenation index (OI) within 72 h of sepsis-related ARDS diagnosis.
Between January 1, 2015 and March 13, 2020, 9836 patients were admitted to the pediatric intensive care unit (PICU) of the Children's Hospital of Chongqing Medical University and 828 (8.4%) were identified with sepsis and 203 (24.5%) met the PALICC definition with a PICU mortality rate of 24.6% (50/203) and a 90-day mortality rate of 40.9% (83/203). After adjusting for septic shock, the pediatric logistic organ dysfunction 2 (PELOD-2), high-frequency oscillation ventilation (HFOV), and continuous renal replacement therapy (CRRT), the variables that retained an independent association with increased 90-day mortality in pediatric sepsis-related ARDS included ARDS severity, the pediatric risk of mortality III (PRISM III), number of organ dysfunctions and use of vasoactive drug types during PICU stay.
PICU mortality in pediatric sepsis-related ARDS was high (24.6%) and severity of hypoxemia based on the worst OI value 72 h after meeting the PALICC definition accurately stratified the patient outcomes. ARDS severity, PRISM III score, comorbid multiorgan dysfunction, and use of multiple vasoactive drugs during PICU stay were independent risk factors for 90-day mortality in pediatric sepsis-related ARDS.
描述儿童患者中与急性呼吸窘迫综合征(ARDS)相关的脓毒症的发病率、临床特征、结局和死亡风险因素。
如果患者符合 2005 年国际儿科脓毒症共识会议和脓毒症诊断后 48 小时内符合儿科急性肺损伤共识会议(PALICC)定义,则将其纳入本研究。根据脓毒症相关性 ARDS 诊断后 72 小时内最差的氧合指数(OI),将患者分为轻度、中度和重度。
2015 年 1 月 1 日至 2020 年 3 月 13 日,重庆医科大学儿童医院儿科重症监护病房(PICU)收治 9836 例患者,其中 828 例(8.4%)被诊断为脓毒症,203 例(24.5%)符合 PALICC 定义,PICU 死亡率为 24.6%(50/203),90 天死亡率为 40.9%(83/203)。调整脓毒症休克、儿科器官功能障碍 2 评分(PELOD-2)、高频振荡通气(HFOV)和持续肾脏替代治疗(CRRT)后,与儿科脓毒症相关性 ARDS 90 天死亡率增加相关的独立变量包括 ARDS 严重程度、儿科死亡风险评分 III(PRISM III)、PICU 住院期间器官功能障碍的数量和血管活性药物类型。
儿科脓毒症相关性 ARDS 的 PICU 死亡率较高(24.6%),根据满足 PALICC 定义后 72 小时最差 OI 值,低氧血症的严重程度准确地对患者结局进行分层。ARDS 严重程度、PRISM III 评分、合并多器官功能障碍、PICU 住院期间使用多种血管活性药物是儿科脓毒症相关性 ARDS 90 天死亡率的独立危险因素。